Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
about
Beta-lactamase inhibitors from laboratory to clinicThree decades of beta-lactamase inhibitorsIn vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolatesBeta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosaEffect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillinSpontaneous bacterial peritonitis: Analysis of treatment and outcome.Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acidDisk diffusion susceptibility testing of ticarcillin plus clavulanic acidAntimicrobial therapy for the elderly patient.Screening and isolation of antibiotic resistance inhibitors from herb materials IV-resistance inhibitors from Anetheum graveolens and Acorus gramineus.Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.New antibiotics. New hopes and new problems.Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.Effect of clavulanic acid on the minimum inhibitory concentration of benzylpenicillin, ampicillin, carbenicillin, or cephalothin against clinical isolates resistant to beta-lactam antibioticsPharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid.Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.Pharmacokinetics and bioavailability of ticarcillin and clavulanate in foals after intravenous and intramuscular administration.In vitro susceptibilities of feline and canine Escherichia coli and Pseudomonas spp. isolates to ticarcillin and ticarcillin-clavulanic acid.Serum levels and pharmacokinetics of ticarcillin and clavulanic acid in dog following parenteral administration of Timentin.Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.Augmentin (amoxycillin and clavulanic acid) in the treatment of urinary tract infections.Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
P2860
Q24617277-6A0F775A-53A0-4405-B532-FDBAAC2D31B7Q24646623-7DE5EB73-D6EF-47E3-AE54-E5F24E28DD96Q24681289-12769278-69F5-4BD3-A3CD-D24D53FE6B23Q34042624-F2FBF8C9-C50C-4924-880B-A722006B80B9Q35570220-8AE08AC3-B9AE-4DF1-A1E5-F8AF2CCB0981Q35574130-9B072DAC-917F-4C08-830A-59699CA35D89Q35575219-D4D1A58A-BA40-462A-B9CA-1F7FE68D9F6AQ35650267-26815BD2-5AE1-4783-AF9F-85E9E8E22B98Q35672724-28AC5171-E76F-4614-A176-2933467B958CQ35893199-6039E6E7-A333-4D3E-BA29-C2034762BD38Q37162193-CEC2E97A-875A-403A-8F60-45B9AD918ECBQ37263001-1D0B8296-4833-4EA0-9541-ADB30A651C76Q38006505-505B8EDD-C623-4F7C-8B3C-220CBA9AB049Q38528405-8B55CFEC-BAD6-4286-BC84-97BBCF388C25Q39850737-2DCA7B91-FC91-472C-8AB3-0627546F68ABQ40178076-E5519B50-9C9C-4FDD-ACCB-8066D37C0764Q40282177-3D0A1D3B-F42A-42A2-B9ED-2CE91EB32E67Q40283560-E56827F3-90A2-4B7C-8DC9-3263F26402E3Q40620039-98BB0671-8419-4296-BA85-72984DEE303AQ42928992-FBE37C84-11C3-4567-8A1E-5619C8EE77C8Q43484203-4B84EC8D-B833-4014-9F79-4FDF23ECA82EQ46147437-F944BE28-8CB7-40FC-A577-61389D928E9DQ54312560-F76CB5AB-71A4-4DED-83B5-2ECB1DE1006BQ54395901-369B4C14-BD34-40A9-82AF-596E64DBE96BQ54486623-F2C7FF6E-002C-4411-A534-542699E01089Q54524531-13A33129-A88A-4B32-82FF-0B271B0EBA9EQ54549829-0184922C-DDCB-48B6-8AAD-4A7DC4D485EC
P2860
Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Combined activitiy of clavulan ...... istant, gram-negative bacilli.
@en
type
label
Combined activitiy of clavulan ...... istant, gram-negative bacilli.
@en
prefLabel
Combined activitiy of clavulan ...... istant, gram-negative bacilli.
@en
P356
P1476
Combined activitiy of clavulan ...... istant, gram-negative bacilli.
@en
P2093
Paisley JW
Washington JA 2nd
P2860
P304
P356
10.1128/AAC.14.2.224
P407
P577
1978-08-01T00:00:00Z